Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-29FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for simvastatin, resulting in changes to the product's labeling and/or m…
-
FDA approval · 2022-07-08FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approved the supplemental application for atorvastatin calcium from NIVAGEN Pharmaceuticals, Inc., authorizing the generic product.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography [Phase 2]
Phase 2 trial exploring the impact of PCSK9 inhibitors on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular…
-
FDA approval · 2022-03-31FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a ge…
-
FDA approval · 2022-03-07FDA Approved: ZOCOR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for ZOCOR (simvastatin) submitted by Organon LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity [Phase 4]
Phase 4 trial evaluating how evolocumab influences the effects of clopidogrel in patients with high on-treatment platelet reactivity in athe…
-
FDA approval · 2022-02-08FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Zhejiang Yongtai Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for Rosuvastatin Calcium from Zhejiang Yongtai Pharmaceutical Co., Ltd., resulting in an approved su…
-
FDA approval · 2022-02-02FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for the ezetimibe and simvastatin combination product. This action updates the product's labeling fo…
-
FDA approval · 2021-11-30FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic atorvastatin) from Rising Pharma Holdings, Inc., confirming approv…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Subclinical Cardiovascular Disease in Psoriatic Disease [Phase 4]
Phase 4 clinical trial update on subclinical cardiovascular disease in psoriatic disease; study completed with posted results.
-
FDA approval · 2021-09-15FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for the ezetimibe and simvastatin combination product from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2021-08-31FDA Approved: SIMVASTATIN — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for simvastatin submitted by XLCare Pharmaceuticals Inc., approving changes under the ANDA.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia [Phase 3]
Phase 3 outcomes study completed; FocaSThStatin residual risk reduction with EPA in high cardiovascular risk patients with hypertriglyceride…
-
FDA approval · 2021-07-14FDA Approved: ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' atorvastatin calcium as a generic tablet under an Original Application (ANDA214659), authorizing …
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term [NA]
A completed clinical trial evaluating aspirin dosing for patients with atherosclerotic cardiovascular disease; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease [Phase 2]
Phase 2 clinical trial evaluating Exercise Treadmill Test indices in participants with cardiovascular disease has terminated; results posted…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension [Phase 4]
A Phase 4 trial comparing high-dose statin plus telmisartan versus amlodipine evaluating effects on glucose metabolism in patients with athe…
-
FDA approval · 2021-05-17FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for atorvastatin calcium by Accord Healthcare Inc., authorizing the continued commercialization of t…
-
FDA approval · 2021-05-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for atorvastatin calcium, authorizing the atorvastatin calcium product unde…
-
FDA approval · 2021-05-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA granted supplemental approval for atorvastatin calcium from Dr. Reddy's Laboratories Limited under an ANDA.
-
FDA approval · 2021-03-17FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for a generic ezetimibe and simvastatin product from Dr. Reddy's Laboratories, authorizing its marke…
-
FDA approval · 2021-03-15FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium to allow Aurobindo Pharma Limited to market a generic pravastatin product in …
-
FDA approval · 2021-03-05FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's generic pravastatin sodium, updating its regulatory status as an approved ge…
-
FDA approval · 2021-02-26FDA Approved: REPATHA — Original Application (Amgen USA Inc.)
FDA approved Repatha (evolocumab) from Amgen USA Inc. in an original application to lower LDL cholesterol in adults with familial hyperchole…
-
FDA approval · 2021-02-23FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for EZETIMIBE AND SIMVASTATIN by Ascend Laboratories, LLC. The approval covers changes under the…